We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+7.02%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$4.22B
AUM Growth
-$873M
Cap. Flow
-$1.18B
Cap. Flow %
-28.02%
Top 10 Hldgs %
31.05%
Holding
110
New
22
Increased
26
Reduced
27
Closed
30

Top Buys

Rank Stock Value
1
BIDU icon
Baidu
BIDU
+$94.6M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$79.4M
3
ZBH icon
Zimmer Biomet
ZBH
+$78.6M
4
DVA icon
DaVita
DVA
+$74.5M
5
HOLX
Hologic
HOLX
+$69M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$103M
2
CNC icon
Centene
CNC
+$85.6M
3
AGN.PRA
Allergan plc
AGN.PRA
+$79.2M
4
JD icon
JD.com
JD
+$78.6M
5
ELV icon
Elevance Health
ELV
+$77.6M

Sector Composition

Rank Sector Weight
1 Healthcare 48.28%
2 Technology 12.7%
3 Communication Services 3.9%
4 Financials 3.09%
5 Consumer Discretionary 2.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PTLA
1
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$289M 6.86%
5,941,055
+862,909
+17% +$43.6M
PBYI icon
2
Puma Biotechnology
PBYI
$422M
$180M 4.27%
1,821,800
+452,221
+33% +$50.6M
AERI
3
DELISTED
Aerie Pharmaceuticals
AERI
$156M 3.69%
2,607,211
+193,750
+8% +$11.7M
QQQ icon
4
PUT
Invesco QQQ Trust
QQQ
$471B
$109M 2.59%
701,100
-1,998,800
-74% -$305M
EW icon
5
Edwards Lifesciences
EW
$48.9B
$101M 2.39%
2,679,849
-432,423
-14% -$15.9M
ABT icon
6
Abbott
ABT
$174B
$98.9M 2.35%
1,732,542
-68,426
-4% -$3.79M
GDDY icon
7
GoDaddy
GDDY
$12.2B
$97.7M 2.32%
1,943,528
-539,167
-22% -$25.6M
XBI icon
8
PUT
State Street SPDR S&P Biotech ETF
XBI
$10.4B
$95.7M 2.27%
+1,127,200
New +$94.4M
BIDU icon
9
Baidu
BIDU
$36.8B
$90.7M 2.15%
+387,046
New +$94.6M
MOH icon
10
Molina Healthcare
MOH
$12B
$90.1M 2.14%
1,174,777
+458,683
+64% +$33.1M
DVA icon
11
DaVita
DVA
$15B
$87.4M 2.07%
+1,210,282
New +$74.5M
JUNO
12
DELISTED
Juno Therapeutics, Inc.
JUNO
$84.6M 2.01%
1,850,820
+400,213
+28% +$20M
CRM icon
13
Salesforce
CRM
$139B
$84M 1.99%
822,080
-133,487
-14% -$13.6M
BAX icon
14
Baxter International
BAX
$11.5B
$82.4M 1.95%
1,274,017
-368,651
-22% -$23.7M
UNH icon
15
UnitedHealth
UNH
$396B
$82.1M 1.95%
372,408
+67,336
+22% +$14.3M
ZBH icon
16
Zimmer Biomet
ZBH
$17.4B
$81.4M 1.93%
+695,052
New +$78.6M
PEN icon
17
Penumbra
PEN
$12.5B
$77.7M 1.84%
825,512
+234,839
+40% +$23.3M
ACOR
18
DELISTED
Acorda Therapeutics
ACOR
$74M 1.76%
28,763
-5,006
-15% -$14.2M
HOLX
19
DELISTED
Hologic
HOLX
$74M 1.75%
+1,730,384
New +$69M
REGN icon
20
Regeneron Pharmaceuticals
REGN
$70.5B
$73.7M 1.75%
+196,112
New +$79.4M
HUM icon
21
Humana
HUM
$47.8B
$73.1M 1.73%
294,480
+93,290
+46% +$23M
NOW icon
22
ServiceNow
NOW
$105B
$68.8M 1.63%
2,636,705
+755
+0% +$18.8K
RVTY icon
23
Revvity
RVTY
$12.3B
$65.7M 1.56%
898,160
+223,893
+33% +$16.1M
BPMC
24
DELISTED
Blueprint Medicines
BPMC
$65.4M 1.55%
866,740
-762,346
-47% -$53.6M
HCA icon
25
HCA Healthcare
HCA
$82.8B
$64.3M 1.53%
+732,007
New +$58.8M
1
2 3 4 5

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
CPRC
Consolidated Portfolio Review Corp Woodbury, New York $1.1B AUM 8.96% 1-Year Est. Return
AWP
Abacus Wealth Partners Santa Monica, California $1.1B AUM 14.74% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return

PFM Health Sciences's Q4 2017 Portfolio in Review

As of Q4 2017, PFM Health Sciences held 110 positions worth $4.22B, down 17% from $5.09B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

PFM Health Sciences withdrew a net $1.18B in Q4 2017, closing 30 positions and reducing 27 holdings. Its most notable exit was Centene, an estimated $85.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, up from 33% a quarter earlier, followed by Technology and Communication Services.

Against the trend, PFM Health Sciences opened a new position in Baidu worth $90.7M.

  • PFM Health Sciences's largest Q4 2017 buy was Baidu: 387,046 shares worth $90.7M.
  • PFM Health Sciences added most to Puma Biotechnology in Q4 2017, an estimated $50.6M increase.
  • PFM Health Sciences's biggest Q4 2017 reduction was Meta Platforms (Facebook), cutting an estimated $103M.
  • PFM Health Sciences fully exited Centene in Q4 2017, selling an estimated $85.6M.
  • PFM Health Sciences's ten largest holdings make up 31% of its $4.22B portfolio in Q4 2017.
  • PFM Health Sciences opened 22 new positions and closed 30 in Q4 2017.
  • PFM Health Sciences's portfolio value fell 17% quarter-over-quarter to $4.22B.

Based on PFM Health Sciences's 13F filing for Q4 2017, filed 14 Feb 2018.